Cambridge Cancer Genomics Investors
Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response.
Investors
Connections from
Industry:
Other
Employee Number:
11-50
Technology:
Other
Investor Type:
Healthcare Company
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2016